Medrx reports nine-month net loss of ¥824 million

Medrx Co. Ltd. recorded a net loss of ¥824 million for the nine months ended Sept. 30, compared with a loss of ¥769 million in the same period of 2025, under Japanese accounting standards.

November 13, 2026, 09:45 AM 290 0

Medrx reports nine-month net loss of ¥824 million

Revenue fell to ¥13 million from ¥118 million. Operating loss widened to ¥896 million from ¥742 million, while pretax loss increased to ¥822 million from ¥757 million.

The loss per share narrowed to ¥13.30 from ¥14.84. All figures are for the nine-month periods ended Sept. 30; losses are shown in parentheses in the company’s reported results.

When reusing this material a link to Money Talk is required.